Hikma Pharmaceutical | HIK - Операционный доход





Операционный доход Изменить Дата
Almirall EUR 71.55M 41.32M 2026-06
argenx SE USD 493M 99M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
Autolus Therapeutics Ltd USD -59.51M 12.95M 2026-03
Bayer EUR 827M 2.7B 2026-06
Fresenius EUR 719M 118M 2026-06
Genmab DKK 407M 182M 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
GRIFOLS EUR 329M 80M 2026-06
Hikma Pharmaceutical USD 348M 161M 2025-12
Lakefront Biotherapeutics EUR -43.51M 20.19M 2026-06
Lonza CHF 673M 243M 2025-06
Merck EUR 1.1B 51M 2026-06
Orion EUR 176.6M 61.8M 2026-06
Recordati EUR 203.76M 27.35M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 2.38B 449M 2026-06
UCB EUR 1.29B 571M 2025-12